App Provides Immediate Access to Company News and Financial Information
EMERYVILLE, Calif., Jan. 15, 2013 (GLOBE NEWSWIRE) -- NovaBay ® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biotechnology company focused on addressing the large unmet therapeutic needs of the global anti-infective market with first-in-class compounds such as its proprietary Aganocides®, has launched its Mobile Shareholder Smartphone investor application.
NovaBay's new Mobile Shareholder Smartphone application will be available for free download through Apple's App Store and Android's Google Play. The InvestorApp provides users with the ability to quickly obtain NovaBay's news, SEC filings, posters & publications, social media sites, media animations, the CEO's Blog and financial information via Smartphone or tablet with the touch of the NovaBay icon. Users who download the App will also be able to set-up push notification to alert them whenever NovaBay has released news, filed a report with the SEC or hit a price target that they have predetermined in the App's settings.NovaBay also announced an updated and easier to use website at a new domain: www.NovaBay.com . "The launch of NovaBay's innovative mobile application and updated website allows for us to more effectively communicate with our investment community," said Dr. Ron Najafi, chairman and chief executive officer of NovaBay. "We are excited about the investor app, as it will provide direct and real-time mobile access to company news and financial information relevant to NovaBay. Thanks to Mobile Shareholder's proprietary technology, users are able to customize the application to their specific business needs on iPhone, iPad and Android." NovaBay's Mobile Shareholder Smartphone investor application allows for its shareholders and investment community to have rapid availability to its financial data, press releases, events and conference participation, SEC filings, the CEO's blog, audio/video content and other related materials they wish to attain.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts